Schiller Mark C. 4
4 · Kezar Life Sciences, Inc. · Filed Jul 26, 2024
Insider Transaction Report
Form 4
Schiller Mark C.
Chief Legal Officer
Transactions
- Sale
Common Stock
2024-07-02$0.58/sh−6,688$3,879→ 33,007 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.